Harnessing the power of biological macromolecules in hydrogels for controlled drug release in the central nervous system: A review

• Published in: International journal of biological macromolecules 2024-01, Vol.254 (Pt 1), p.127708-127708, Article 127708
• Main Authors: Ghosh, Shampa, Ghosh, Soumya, Sharma, Hitaishi, Bhaskar, Rakesh, Han, Sung Soo, Sinha, Jitendra Kumar
• Format: Article
• Language: English
• Subjects: alginates; biocompatibility; biodegradability; bioprinting; central nervous system; chitosan; crosslinking; drug delivery systems; Drug release kinetics; drugs; hyaluronic acid; hydrogels; Macromolecules; nanotechnology; Natural hydrogels; peptides; porosity; Stimuli-responsive hydrogels; Targeted CNS drug delivery
• ISSN: 0141-8130; 1879-0003
• DOI: 10.1016/j.ijbiomac.2023.127708

Hydrogels have immense potential in revolutionizing central nervous system (CNS) drug delivery, improving outcomes for neurological disorders. They serve as promising tools for controlled drug delivery to the CNS. Available hydrogel types include natural macromolecules (e.g., chitosan, hyaluronic acid, alginate), as well as hybrid hydrogels combining natural and synthetic polymers. Each type offers distinct advantages in terms of biocompatibility, mechanical properties, and drug release kinetics. Design and engineering considerations encompass hydrogel composition, crosslinking density, porosity, and strategies for targeted drug delivery. The review emphasizes factors affecting drug release profiles, such as hydrogel properties and formulation parameters. CNS drug delivery applications of hydrogels span a wide range of therapeutics, including small molecules, proteins and peptides, and nucleic acids. However, challenges like limited biodegradability, clearance, and effective CNS delivery persist. Incorporating 3D bioprinting technology with hydrogel-based CNS drug delivery holds the promise of highly personalized and precisely controlled therapeutic interventions for neurological disorders. The review explores emerging technologies like 3D bioprinting and nanotechnology as opportunities for enhanced precision and effectiveness in hydrogel-based CNS drug delivery. Continued research, collaboration, and technological advancements are vital for translating hydrogel-based therapies into clinical practice, benefiting patients with CNS disorders. This comprehensive review article delves into hydrogels for CNS drug delivery, addressing their types, design principles, applications, challenges, and opportunities for clinical translation.